A triterpene saponins compound, and a preparation method and application thereof
Patent Information
- Application Number
- CN202610984657.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2026-07-03
- Publication Date
- 2026-11-03
AI Technical Summary
No triterpenoid saponin monomers with a clear chemical structure have been isolated from common camellia flowers in the current technology, and their protective effect against oxidative damage to skin cells has not been reported, which limits the in-depth development of this plant resource and the application of related active ingredients in functional cosmetics.
A separation and purification strategy combining ethanol extraction, macroporous adsorption resin column chromatography, silica gel column chromatography, and preparative high-performance liquid chromatography was used to extract and isolate triterpenoid saponins from Camellia chrysantha flowers. These saponins were named Camellia chrysantha saponin G and are used to prepare cosmetics for delaying skin aging.
This compound has a significant protective effect against AAPH-induced oxidative damage to HaCaT keratinocytes, can improve cell survival under oxidative damage conditions, and shows the potential to promote cell proliferation at higher concentrations. It provides a new active ingredient for the development of skin aging delay cosmetics with independent intellectual property rights.
Smart Images

Figure CN123026656A_ABST
Abstract
Description
Technical Field
[0001] This invention belongs to the fields of skin care technology and phytochemistry, specifically relating to a triterpenoid saponin compound extracted and isolated from common camellia flowers and its preparation method, and particularly to the application of this triterpenoid saponin compound in the preparation of cosmetics that delay skin aging. Background Technology
[0002] *Camellia chrysantha*, belonging to the genus *Camellia* in the family Theaceae, is notable for its distinctive golden-yellow petals and is primarily distributed in northern Vietnam and southern and southwestern Guangxi, China. This plant not only possesses high ornamental value but also has a long history of use in local folk medicine, with its leaves and petals often used to treat diarrhea, tumors, and as immunomodulators. In recent years, with the deepening of natural product chemistry research, the chemical composition of *Camellia chrysantha* has gradually attracted researchers' attention. Existing chemical studies have shown that the leaves of *Camellia chrysantha* are rich in various types of secondary metabolites, including flavonoids, triterpenoid saponins, and polyphenols, which are considered to be closely related to its various biological activities. However, compared to the leaves, chemical and biological research on the flowers of *Camellia chrysantha* started relatively late. Current reports mainly focus on the structural identification and functional evaluation of flavonoid components, while systematic studies on triterpenoid saponins, which are also abundant in the flowers, are very scarce. Their specific chemical composition, structural characteristics, and potential biological activities remain unclear.
[0003] Triterpenoid saponins are a class of natural products widely distributed and structurally diverse in the plant kingdom. They possess various pharmacological effects, including anti-inflammatory, antioxidant, antitumor, and immunomodulatory properties, showing promising development prospects in both cosmetics and pharmaceuticals. In skin protection, oxidative stress is considered a major contributing factor to skin cell damage and aging. Environmental ultraviolet radiation, pollutants, and endogenous metabolic disorders can induce cells to produce excessive reactive oxygen species, which then attack cell membranes, proteins, and nucleic acids, triggering lipid peroxidation, collagen degradation, and inflammatory responses, ultimately accelerating the skin aging process. Therefore, identifying active ingredients with antioxidant or damage-protective activities from natural plants has become an important research direction for developing cosmetics that delay skin aging. Keratinocytes are the main cell type in the epidermis, and their functional state directly affects the integrity and regenerative capacity of the skin barrier. In oxidative damage models, protecting keratinocytes from oxidative attack is often considered a key indicator for evaluating the skin-protective activity of candidate products.
[0004] Currently, while some anti-aging cosmetics on the market use plant extracts as their main active ingredients, most are limited to common flavonoids or polyphenols, exhibiting significant homogeneity in their sources. However, triterpenoid saponins derived from common camellia flowers hold promise as a new class of active ingredients due to their novel structure and potential skin cell protective activity. Unfortunately, existing technologies have not yet reported on the isolation of triterpenoid saponin monomers with clearly defined chemical structures from common camellia flowers, nor have they systematically evaluated their protective effects against oxidative damage to skin cells. This gap not only limits our understanding of the in-depth development and utilization of common camellia flower resources but also hinders the exploration of related active ingredients in functional cosmetics. Therefore, it is necessary to systematically isolate, purify, and screen the activity of triterpenoid saponins from common camellia flowers in order to discover novel compounds with skin-protective activity and provide a material basis and technical support for developing anti-aging cosmetics with independent intellectual property rights. Summary of the Invention
[0005] Technical Problem Solved: To address the lack of existing technologies for isolating triterpenoid saponin monomers with clearly defined chemical structures from common camellia flowers, and the absence of reported protective effects of such components against oxidative damage to skin cells, this invention provides a triterpenoid saponin compound extracted and isolated from common camellia flowers, its preparation method, and its applications. This triterpenoid saponin compound, named common camellia saponin G, is the first of its kind isolated from nature. Its preparation method employs a separation and purification strategy combining ethanol extraction, macroporous adsorption resin column chromatography, silica gel column chromatography, and preparative high-performance liquid chromatography. This approach enables the acquisition of novel and highly pure target compounds from common camellia flowers, thus filling the gap in existing research on triterpenoid saponin monomers from common camellia flowers. Meanwhile, this invention also provides the application of this triterpenoid saponin compound in the preparation of cosmetics for delaying skin aging. Pharmacological experiments show that this compound has a significant protective effect against AAPH-induced oxidative damage to HaCaT keratinocytes, effectively improving cell survival under oxidative damage conditions, and exhibiting good concentration dependence. At higher concentrations, it even shows the potential to promote cell proliferation. Compared with common flavonoid or polyphenol anti-aging active ingredients in the prior art, the triterpenoid saponin compound provided by this invention has advantages such as novel structure, unique source, and significant activity, providing new functional raw materials and material basis for developing cosmetics for delaying skin aging with independent intellectual property rights.
[0006] Technical solution: A triterpenoid saponin compound, the structure of which is shown in Formula I:
[0007]
[0008] Formula I.
[0009] The preparation method of the above-mentioned triterpenoid saponins includes the following steps: pulverizing Camellia chrysantha flowers and extracting them with an ethanol-water solution; concentrating the extract under reduced pressure to obtain an extract; dissolving the extract in an ethanol-water solution and passing it through a macroporous adsorption resin column, eluting sequentially with low-concentration ethanol solution, medium-concentration ethanol solution, and high-concentration ethanol solution; collecting the high-concentration ethanol eluent and concentrating it under reduced pressure to obtain total saponins from Camellia chrysantha flowers; subjecting the total saponins from Camellia chrysantha flowers to silica gel column chromatography, eluting sequentially with a mixed solvent of methanol and dichloromethane, and collecting the target components; preparing the target components using preparative high-performance liquid chromatography to obtain the triterpenoid saponins represented by Formula I.
[0010] The mass-to-volume ratio of the above-mentioned common camellia flowers to the ethanol aqueous solution is 1 kg: (5-20) L; the volume concentration of the ethanol aqueous solution used for extraction is 40% to 100%.
[0011] In the macroporous adsorption resin column chromatography described above, the ethanol concentration of the low-concentration ethanol solution is 10% to 35%, the ethanol concentration of the medium-concentration ethanol solution is 40% to 55%, and the ethanol concentration of the high-concentration ethanol solution is 60% to 100%.
[0012] In the silica gel column chromatography described above, the gradient elution volume ratios of methanol and dichloromethane were 1:20, 1:15, 1:10, 1:5, 1:3, and 1:1, respectively.
[0013] The detection wavelength for the above-mentioned high-performance liquid chromatography was 225 nm, the chromatographic column was a reversed-phase C-18 column, and the mobile phase was acetonitrile and water.
[0014] The application of the above-mentioned triterpenoid saponins in the preparation of cosmetics that delay skin aging.
[0015] Cosmetics that delay skin aging contain the aforementioned triterpenoid saponins as active ingredients.
[0016] The dosage forms of the aforementioned anti-aging cosmetics are creams, lotions, gels, powders, liquid preparations, or sprays.
[0017] Beneficial Effects: This invention provides the first-ever isolation of triterpenoid saponins (Formula I) from *Camellia chrysantha* flowers, enriching the chemical composition library of *Camellia chrysantha* and providing a new material basis for the subsequent development and utilization of this plant resource. The preparation method of this compound involves an organic combination of steps including ethanol extraction, macroporous adsorption resin column chromatography, silica gel column chromatography, and preparative high-performance liquid chromatography. These steps work synergistically to efficiently enrich and purify single triterpenoid saponins with pharmacodynamic purity from *Camellia chrysantha* flower extracts rich in various secondary metabolites, providing a reliable sample source for further activity studies of this type of component. Simultaneously, this invention reveals for the first time the application of this triterpenoid saponin compound in skin protection. Pharmacological experiments show that this compound has a significant protective effect against AAPH-induced oxidative damage to HaCaT keratinocytes, effectively alleviating the damage to skin cells caused by oxidative stress. This discovery provides a new functional ingredient for the development of cosmetics that delay skin aging. More importantly, this invention organically links plant-derived triterpenoid saponin compounds with specific structures to the specific application of protecting skin cells from oxidative damage. The structural novelty of the compounds themselves and their significant cell-protective activity support each other, together constituting the technical advantages of this invention in the field of functional cosmetics, and possessing high application value and market prospects. Attached Figure Description
[0018] Figure 1 The 1H NMR spectrum of compound 1.
[0019] Figure 2 This is the carbon NMR spectrum of compound 1.
[0020] Figure 3 To assess the toxicity and cytoprotective activity of compound 1. Detailed Implementation
[0021] The technical solution of the present invention will now be clearly and completely described with reference to the accompanying drawings. Obviously, the described embodiments are only some, not all, of the embodiments of the present invention. Based on the embodiments of the present invention, all other embodiments obtained by those skilled in the art without creative effort are within the scope of protection of the present invention.
[0022] Furthermore, the technical features involved in the different embodiments of the present invention described below can be combined with each other as long as they do not conflict with each other.
[0023] Example 1: Preparation of Compound I (Compound 1)
[0024] Plant source: Common golden camellia flowers were provided by Guangxi Guoming Golden Camellia Technology Co., Ltd. in March 2025.
[0025] Extraction and separation of common Camellia chrysantha flowers: Dried Camellia chrysantha flowers (2.82 kg) were crushed and extracted three times with 30 L of 80% ethanol at 60 °C for 12 hours each time. The extracts were combined and concentrated under reduced pressure to obtain a brown extract (394 g). The extract was dissolved in 7.5 L of 25% ethanol with thorough stirring. The solution was slowly poured into an HPD-100 macroporous resin column (5 kg), and eluted sequentially with 20 L of 35% ethanol, 20 L of 55% ethanol, and 20 L of 75% ethanol. The eluents were concentrated under reduced pressure to obtain 123.4 g of 35% ethanol eluent, 57.8 g of 55% ethanol eluent, and 76.3 g of 75% ethanol eluent, respectively. The 75% ethanol eluent was subjected to silica gel column chromatography (100-200 mesh, 625 g, Qingdao Marine Chemical Plant) with six gradient elutions using methanol-dichloromethane (1:20, 1:15, 1:10, 1:5, 1:3, and 1:1, v / v), with each gradient elution solvent volume being 5 column volumes (column volume 500 mL). The fractions were combined by thin-layer chromatography, yielding a total of 8 fractions (fractions 1-8). Fraction 3 (2.1 g) was prepared by preparative high-performance liquid chromatography under the following conditions: detection wavelength 225 nm, reversed-phase C-18 column (Unisil-10-120-C18, 250 mm × 50 mm, 9 μm), and acetonitrile and water as the mobile phase (65:35, v / v), yielding compound 1 (18.0 mg, t). R = 41.2 min).
[0026] Example 2
[0027] Compound I (Compound 1) is an amorphous white powder. HR-ESI-MS in negative ion mode yields a quasi-molecular ion peak at m / z 1151.5674 [MH]⁻ (calculated value 1151.5633). 1 H NMR and 13 The C10 NMR data (Table 1) determined its molecular formula to be C10. 58 H 88 O 23 .exist 1 The high-field region of the 1H NMR spectrum gives characteristic signals of the six methyl groups belonging to triterpenoids: δ H 0.88, 3H, s, H-29; 1.02, 3H, s, H-26; 1.04, 3H, s, H-25; 1.10, 3H, s, H-30; 1.11, 3H, s, H-24 and 1.45, 3H, s, H-27. 1 The 1H NMR spectrum gives a single olefin proton signal in the low-field region: δH 5.49, 1H, t, J = 3.6 Hz, H-12. In the ¹³C NMR spectrum, the chemical shifts for C-12 and C-13 are δ C 126.7 and 143.7 suggest that compound 1 is an oleanane-type triterpenoid. HSQC spectra show that the aglycone of compound 1 contains one hydroxymethylene group: 3.03, 3.32 (2H, d, J = 11.2 Hz, H-28) / 63.8 (C-28), and also contains five hydroxymethylene groups: δ H / δ C The values of 3.89 (1H, m, H-3) / 83.7 (C-3), 3.76 (1H, m, H-15) / 68.5 (C-15), 3.82 (1H, d, J = 3.9 Hz, H-16) / 74.3 (C-16), 5.94 (1H, d, J = 10.2 Hz, H-21) / 79.6 (C-21), and 5.61 (1H, d, J = 10.2 Hz, H-22) / 74.0 (C-22) indicate that compound 1 is a highly oxidized triterpenoid. The HSQC spectrum also shows that compound 1 contains an aldehyde group: 9.41 (1H, s, H-23) / 208.8 (C-23). In the ¹H NMR spectrum, δ... H Proton signals of 1.83 (3H, t, J = 1.4 Hz, H-5"), 1.84 (3H, t, J = 1.3 Hz, H-5"), 1.91 (3H, m, H-4"), 1.92 (3H, m, H-4"), 6.06 (1H, m, H-3"), and 6.08 (1H, m, H-3") were combined with δ¹³C NMR spectra. C The carbon signals at 15.9 (C-4"), 16.0 (C-4"), 20.8 (C-5"), 20.9 (C-5"), 129.3 (C-2"), 129.3 (C-2"), 139.1 (C-3"), 139.2 (C-3"), 169.2 (C-1"), and 169.5 (C-1") indicate that compound 1 contains two angelic acyl groups. In the HMBC spectrum, H-21 (δ) H 5.94) and C-1"" (δ C 169.2) has a relevant signal, H-22 (δ) H 5.61) and C-1ʹʺʺ (δ C 169.5) showed a relevant signal, confirming that the two angelic acyl groups were attached to the C-21 and C-22 positions of the aglycone, respectively. In the NOESY spectrum, H-21 (δ) H 5.94) and H-29 (δ) HA related signal exists at 0.88, H-22 (δ) H 5.61) and H-30 (δ) H 1.10) A relevant signal is present, suggesting that H-21 is α-oriented and H-22 is β-oriented. Furthermore, H-15 (δ) was also observed in the NOESY spectrum. H 3.76) and H-18 (δ) H 2.65) There is a relevant signal, H-16 (δ) H 3.82) and H-18 (δ) H 2.65) There is a relevant signal, H-15 (δ) H 3.76) and H-16 (δ) H The presence of a relevant signal (3.82) indicates that the hydroxyl groups at both C-15 and C-16 positions are α-oriented. In the HMBC spectrum, H-23 (δ...) H 9.41) and C-4 (δ) C 169.2) There is a relevant signal, H-24 (δ) H 1.11) and C-23 (δ) C A related signal exists at 208.8, which, combined with H-23 (δ) in the NOESY spectrum, indicates a potential connection. H 9.41) and H-5 (δ) H The correlation signal between 1.35 indicates that the aldehyde group is located at position 23 of the aglycone. Comparison of the 1H and 1C NMR spectra of the aglycone of compound 1 with reported data confirms that compound 1 has a very similar aglycone structure to 21β,22α-di-O-angeloyl-15α,16α,23,28-tetrahydroxyolean-12-ene 3β-O-α-L-rhamnopyranosyl-(1→3)-α-L-arabinopyranosyl-(1→3)-β-D-glucuronopyranoside, the only difference being that compound 1 has an aldehyde group at C-23, while the known compounds have a hydroxymethyl group at C-23. ¹H NMR spectra show δ¹⁸ ... H Proton signals at 4.55 (¹H, d, J = 7.9 Hz, H⁻¹′), 4.54 (¹H, d, J = 7.4 Hz, H⁻¹″), and 5.08 (¹H, brs, H⁻¹‴), and δ¹³C NMR spectrum. C Carbon signals at 105.7 (C-1′), 105.8 (C-1″), and 103.7 (C-1‴) indicate the presence of three glycosyl groups in compound 1. Alkaline and acidic hydrolysis of compound 1 yielded D-glucuronic acid, L-arabinose, and L-rhamnose. HSQC spectroscopy revealed that compound 1 contains a methoxy group: δ H / δC 3.78 (3H, s, -OCH3) / 52.9 (-OCH3); In the HMBC spectrum, this methoxy group (δ H 3.78) and carbonyl (δ) C Related to 171.0), it was confirmed that compound 1 contains methyl D-glucuronide residues. The coupling constant of the terminal hydrogens indicates that methyl D-glucuronide (J... 1 / 2 =7.8 Hz) and L-arabinose (J 1 / 2 = 7.4 Hz) for β-configuration and α-configuration, respectively, while the chemical shift values (δ) of L-rhamnose at C-3‴ and C-5‴ are 7.4 Hz. C (72.1 and 70.2) confirm that L-rhamnose has the α-configuration. In the HMBC spectrum, H-1′ (δ H 4.33) and C-3 (δ) C 83.7) There is a correlation, H-1″ (δ H 4.49) and C-3′ (δ C 86.1) There is a correlation, H-1‴(δ) H 5.04) and C-3'' (δ) C (80.6) A correlation exists, clarifying the linkage sequence and sites of the sugar chains. Based on the above analysis, the chemical structure of compound 1 can be determined and named *Camellia oleifera* saponin G. The NMR spectra of compound 1 were fully assigned according to 1D and 2D NMR (as shown in Table 1).
[0028] Table 1. Compound 1 1 H-NMR (600 MHz) and 13 C-NMR (150 MHz) NMR data (CD3OD)
[0029]
[0030] Example 3
[0031] Results and Analysis of Cell Viability Assay by MTT Assay
[0032] HaCaT keratinocytes were cultured in MEM medium containing 10% fetal bovine serum (FBS) and 1% penicillin-streptomycin, and routinely cultured in an incubator at 37°C and 5% CO2. For the experiment, HaCaT cells in the logarithmic growth phase were seeded at an appropriate density in 96-well plates. After cell attachment, different concentrations of the test compound (compound 1) were added for pretreatment for 1 hour, followed by the addition of AAPH (2,2'-azobisisobutylamidine dihydrochloride) solution to a final concentration of 10 mM, and cultured for another 24 hours to induce oxidative damage. 10 μL of MTT solution (5 mg / mL, prepared with phosphate buffer) and 90 μL of serum-free medium were added to each well, and incubation was continued for 4 hours. Four hours later, the supernatant in each well was carefully aspirated, and 100 μL of MTT stop solution was added to each well. The mixture was incubated overnight at 37°C until the blue-purple formazan crystals were completely dissolved. The absorbance of each well was then measured at 570 nm using a microplate reader. The cell viability of the normal control group (without the added compound and AAPH) was set at 100%, and the cell viability of each treatment group was calculated. The experiment was independently repeated three times, with three replicates per well.
[0033] This invention evaluated the protective effect of compound 1 against AAPH-induced oxidative stress damage in HaCaT keratinocytes. The results showed that, compared with the normal control group, the cell viability of the AAPH model group (treated with 10 mM AAPH for 24 hours) was significantly reduced, indicating that AAPH successfully induced oxidative cell damage and established a stable oxidative stress model. AAPH, as a water-soluble azo compound, can spontaneously decompose at physiological temperatures to generate free radicals, inducing cell membrane lipid peroxidation and protein oxidative damage, ultimately leading to reduced cell viability. Compound 1 exhibited a strong and concentration-dependent cytoprotective effect under the above experimental conditions. As the concentration of compound 1 increased, the cell viability gradually increased from 45.52% to 103.04% (…). Figure 3 The highest concentration group showed a cell survival rate that was even slightly higher than that of the normal control group, indicating that compound 1 can not only completely antagonize AAPH-induced oxidative damage within the tested concentration range, but may also promote cell proliferation or activate the endogenous antioxidant defense system.
Claims
1. A triterpenoid saponin compound, characterized in that, The structure of the triterpenoid saponin compound is shown in Formula I: Formula I.
2. The method for preparing the triterpenoid saponin compound according to claim 1, characterized in that, Includes the following steps: The golden camellia flowers were pulverized and extracted with an ethanol-water solution. The extract was then concentrated under reduced pressure to obtain a paste. The extract was dissolved in an ethanol-water solution and passed through a macroporous adsorption resin column. It was then eluted sequentially with low-concentration ethanol solution, medium-concentration ethanol solution and high-concentration ethanol solution. The high-concentration ethanol eluent was collected and concentrated under reduced pressure to obtain total saponins from Camellia chrysantha. Total saponins from common Camellia chrysantha flowers were collected by silica gel column chromatography with gradient elution using a mixed solvent of methanol and dichloromethane. The target components were then prepared by preparative high-performance liquid chromatography to obtain triterpenoid saponin compounds represented by Formula I.
3. The preparation method according to claim 2, characterized in that, The mass-to-volume ratio of common camellia flowers to ethanol aqueous solution is 1 kg: (5-20) L; the volume concentration of ethanol in the ethanol aqueous solution used for extraction is 40% to 100%.
4. The preparation method according to claim 2, characterized in that, In the macroporous adsorption resin column chromatography, the ethanol concentration of the low-concentration ethanol solution is 10% to 35%, the ethanol concentration of the medium-concentration ethanol solution is 40% to 55%, and the ethanol concentration of the high-concentration ethanol solution is 60% to 100%.
5. The preparation method according to claim 2, characterized in that, In the silica gel column chromatography, the gradient elution volume ratios of methanol and dichloromethane are 1:20, 1:15, 1:10, 1:5, 1:3 and 1:1, respectively.
6. The preparation method according to claim 2, characterized in that, The detection wavelength for the prepared high-performance liquid chromatography was 225 nm, the chromatographic column was a reversed-phase C-18 column, and the mobile phase was acetonitrile and water.
7. The use of the triterpenoid saponin compound according to claim 1 in the preparation of cosmetics for delaying skin aging.
8. Cosmetics for delaying skin aging, characterized in that, It contains the triterpenoid saponin compound as described in claim 1 as an active ingredient.
9. The anti-aging cosmetic product according to claim 8, characterized in that, The dosage forms of the skin-aging-delaying cosmetics are creams, lotions, gels, powders, liquid preparations, or sprays.
